IJMSC: CMSC Consensus Statement on Neurofilament Biomarkers in Multiple Sclerosis

This consensus document was developed by an international panel of experts on neurofilament biomarker research and clinical applications in MS, in partnership with the Consortium of Multiple Sclerosis Centers (CMSC). The panelists met in two virtual consensus conferences held on September 3, 2020 and October 16, 2020 to comprehensively review available data, determine practical applications of the data for MS, and debate conflicting information and unanswered questions.

This continuing education supplement is supported by educational

grants from Biogen and Sanofi Genzyme

About Me

The Continuing Medical Education Program is an integral part of the organization’s overall mission which aims to improve learners’ competence and performance‐in‐practice and ultimately improve patient outcomes.

Related Posts